## Abstract We have previously shown that one of the rapid nongenomic actions of 1α,25‐dihydroxyvitamin D~3~ (1α,25‐(OH)~2~D~3~), the increase in intracellular calcium (Ca^2+^), accompanies the increased osteocalcin (OC) mRNA steady‐state levels in rat osteosarcoma cells. To determine the functiona
1α,25-Dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression
✍ Scribed by Louis G. Jenis; Jane B. Lian; Gary S. Stein; Dr. Daniel T. Baran
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 563 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
1α,25‐Dihydroxyvitamin D~3~ exerts rapid nongenomic effects on rat osteoblast‐like cells independent of the classic nuclear receptor. These effects include changes in phospholipid metabolism and cell calcium. Intracellular calcium itself has been proposed to regulate intracellular pH in osteoblast cell lines. The purpose of this study was to determine the effect of 1α,25‐dihydroxyvitamin D~3~ on intracellular pH, the relationship of changes in calcium to changes in pH, and the role of pH changes in genomic activation. 1α,25‐Dihydroxyvitamin D~3~ increased intracellular pH within 10 min in rat osteoblast‐like cells, an effect that was inhibited by removal of extracellular sodium and by the biologically inactive epimer 1β,25‐dihydroxyvitamin D~3~. The hormone increased intracellular calcium in Quin 2 loaded cells in the presence and absence of extracellular sodium. The 1α,25‐dihydroxyvitamin D~3~‐induced increments in osteocalcin and osteopontin mRNA levels were abolished in sodium‐free medium. The results indicate that 1α,25‐dihydroxyvitamin D~3~‐induced increments in cellular calcium precede cell alkalinization and that these changes in intracellular pH may modulate steady‐state mRNA levels of genes induced by vitamin D.
📜 SIMILAR VOLUMES
Department of Medicine, Stanford C / / i r ~ er\fl\ S c h o o l o l Medfcfne, S t d i T / o r d Ca/itorii/,r 94 HI5 The level o i l,2.510H)IDl receptors in ( ~i l t ~i i . 4 m o u w o.;teohl,i+likt~ t O l i ) cells is modulated Iiy t h v r,itt' 01 cell ~> r o l i l c ~t ' ~l i o i i .
This report describes an investigation of the role of 1,25-dihydroxyvitamin D (VD 3 ) in the regulation of estrogen receptor-␣ (ER) in the ER-positive breast cancer cell line, MCF-7. Treatment of cells with 10 nM VD 3 resulted in a 50% decline in the concentration of ER protein at 24 h. Scatchard an
Human dermal fibroblasts are generally considered to be restricted to a fibroblastic lineage. Although dermal fibroblasts do not typically express markers of osteoblastic differentiation, they have previously been shown to undergo osteoinduction when stimulated with bone morphogenetic proteins (BMPs
Commitment of members of the monocyte/macrophage family to the bone resorptive phenotype, in vitro, requires contact, of these osteoclast precursors, with osteoblasts or related stromal cells. The osteoclast-inductive properties of these stromal cells are typically expressed, however, only in the pr
The vitamin D receptor (VDR) is a nuclear receptor that mediates the effect of the active metabolite of vitamin D3, the 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). To investigate the potential role of this hormone in the peripheral nervous system, we have studied the VDR expression in Schwann cells. Th